Skip to content

Clinical trials

Completed Phase 3 Schizophrenia trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Schizophrenia Phase: Phase 3 Status: Completed Clear all

311 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20004
20019
200210
200313
200440
200529
200621
200715
200824
20093
201023
201116
201213
201316
20147
20156
201610
20178
20182
20198
20203
202110
20224
20237
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed311

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.32
Otsuka Pharmaceutical Development & Commercialization, Inc.32
Organon and Co18
AstraZeneca16
Sumitomo Pharma America, Inc.13
H. Lundbeck A/S12
Alkermes, Inc.10
Eli Lilly and Company10
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.9
Janssen Research & Development, LLC8

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Schizophrenia311
Psychotic Disorders67
Mental Disorders16
Bipolar Disorder10
Psychomotor Agitation5
Major Depressive Disorder4
Cognition Disorders3
Anxiety Disorders2
Cognitive Dysfunction2
Disease2

Trials

Showing 1 to 25 of 311. Each trial links to its page on Pharma Observatory.

211 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.